Sign In
Buy AMD
$466.38
-56.82 (-10.86%)
At Close: Jun 05, 2026
Technical analyst maps out the ‘massive buy' opportunity for AMD stock
11:36am, Friday, 07'th Mar 2025
Advanced Micro Devices (NASDAQ: AMD) has had a challenging start to 2024, sliding over 18% since the beginning of the year.
Should You Buy AMD Stock on the Dip?
07:07am, Friday, 07'th Mar 2025
Advanced Micro Devices (AMD -2.77%) has been one of the worst stocks to own over the past year. While investors were excited about AMD potentially taking market share from rival Nvidia in the all-impo
2 AI Stocks That Could Be Worth More Than Palantir by 2026
04:15am, Friday, 07'th Mar 2025
Shares of Palantir Technologies (PLTR -10.73%) have had an incredible run the past few years. The stock has rocketed more than 1,000% since 2022, bringing its market cap (share price times total share
AMD: Interesting Combination Of Growth And Valuation
02:52am, Thursday, 06'th Mar 2025
AMD's stock decline to $99 from $211 seems excessive; Wall Street analysts remain bullish, while Seeking Alpha analysts offer more moderate optimism. AMD's diversified business includes Data Center, C
Advanced Micro Devices (AMD) Advances But Underperforms Market: Key Facts
06:46pm, Wednesday, 05'th Mar 2025
In the closing of the recent trading day, Advanced Micro Devices (AMD) stood at $101.67, denoting a +0.91% change from the preceding trading day.
AMD Stock: Opportunity or Falling Knife?
11:47am, Wednesday, 05'th Mar 2025
In this video, I will go over the recent updates regarding AMD (AMD -1.64%). Watch the short video to learn more, consider subscribing, and click the special offer link below.
2 Stocks for Turnaround Tuesday: $ADBE and $AMD
10:44am, Wednesday, 05'th Mar 2025
Could any more bad news hit the market? Of course it can.
Is Advanced Micro Devices Stock Slide Over?
09:58am, Wednesday, 05'th Mar 2025
Advanced Micro Devices NASDAQ: AMD stock slide may not be over, but it is nearing its end and setting up the market for a solid rebound that could quickly add 30% to the stock price. Technically speak
Should You Buy the Dip in AMD Stock?
05:35am, Wednesday, 05'th Mar 2025
For the most part, chip stocks have fared well over the last couple of years. The main tailwind fueling semiconductor stocks to new highs is, of course, rising interest in artificial intelligence (AI)
The Nasdaq Is in a Correction – Here Are 2 Stocks You Can Buy on Sale Right Now
05:18am, Wednesday, 05'th Mar 2025
A stock market correction is generally defined as a drop of 10% from recent highs, and the tech-heavy Nasdaq Composite just got there. The Nasdaq has been the best performing major market index for th
AMD Has a Golden Opportunity in the Graphics Card Market
10:30am, Tuesday, 04'th Mar 2025
The graphics card market is dominated by Nvidia (NVDA -2.64%). The gaming and AI powerhouse has a 90% unit market share, according to Jon Peddie Research, with Advanced Micro Devices (AMD -2.17%) in a
Advanced Micro Devices, Inc. (AMD) is Attracting Investor Attention: Here is What You Should Know
10:00am, Tuesday, 04'th Mar 2025
Advanced Micro (AMD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
2 No-Brainer Artificial Intelligence (AI) Stocks to Buy With $200 in March
05:30am, Tuesday, 04'th Mar 2025
The technology-heavy Nasdaq Composite (^IXIC -2.64%) has tumbled 3% year to date, and that slight decline has created some no-brainer buying opportunities. The market reacted too pessimistically to th
Advanced Micro Devices, Inc. (AMD) Morgan Stanley Global TMT Conference (Transcript)
07:37pm, Monday, 03'rd Mar 2025
Advanced Micro Devices, Inc. (NASDAQ:AMD ) Morgan Stanley Global TMT Conference March 3, 2025 4:05 PM ET Company Participants Matt Ramsey - IR Jean Hu - EVP, CFO and Treasurer Conference Call Particip
Adverum Biotechnologies Initiates ARTEMIS Phase 3 Study Evaluating Ixo-vec for Wet AMD
04:01pm, Monday, 03'rd Mar 2025
REDWOOD CITY, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy to preserve sight for life in highly
